Painting the Bigger Picture: Understanding Overarching ALS Pathology to Allow Novel Sporadic Target Identification

Time: 9:05 am
day: Pre-Conference Day Track A


Understanding disease pathology remains one of the biggest challenges facing ALS drug development. With fast disease progression and complex, multi-system biology, how can we understand underlying causes for sporadic ALS to uncover novel targets to benefit the wider patient population? Join this workshop to explore the cutting-edge research understanding ALS disease biology and how this translates into identifying novel targets for sporadic ALS.

Workshop highlights include:

• Monitoring early disease progression to investigate causes and pathways to sporadic ALS disease progression

• Non-neuronal factors: piecing together global ALS pathology to uncover common threads for novel sporadic targets

• Tackling patient heterogeneity to identify ALS participant subsets for personalized target validation